Application of Rome III vs. Rome IV Diagnostic Criteria for Irritable Bowel Syndrome (IBS) in Clinical Practice: is the Newer the Better?

2017 ◽  
Vol 152 (5) ◽  
pp. S717
Author(s):  
Tanisa Patcharatrakul ◽  
Kessarin Thanapirom ◽  
Sutep Gonlachanvit
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Diagnostic Criteria ◽  
Rome Iii ◽  
Irritable Bowel ◽  
Rome Iv

scholarly journals Functional gastrointestinal disorders in children: agreement between Rome III and Rome IV diagnoses

2021 ◽  
Author(s):  
Desiree F. Baaleman ◽  
Carlos A. Velasco-Benítez ◽  
Laura M. Méndez-Guzmán ◽  
Marc A. Benninga ◽  
Miguel Saps
Keyword(s):  
Diagnostic Criteria ◽  
Functional Dyspepsia ◽  
Functional Gastrointestinal Disorders ◽  
Functional Constipation ◽  
Final Analysis ◽  
Gastrointestinal Disorders ◽  
Rome Iii ◽  
Sample Characteristics ◽  
Irritable Bowel ◽  
Rome Iv

AbstractTo evaluate the agreement between the Rome III and Rome IV criteria in diagnosing pediatric functional gastrointestinal disorders (FGIDs), we conducted a prospective cohort study in a public school in Cali, Colombia. Children and adolescents between 11 and 18 years of age were given the Spanish version of the Questionnaire on Pediatric Functional Gastrointestinal Disorders Rome III version on day 0 and Rome IV version on day 2 (48 h later). The study protocol was completed by 135 children. Thirty-nine (28.9%) children were excluded because of not following the instructions of the questionnaire. The final analysis included data of 96 children (mean 15.2 years old, SD ± 1.7, 54% girls). Less children fulfilled the criteria for an FGID according to Rome IV compared to Rome III (40.6% vs 29.2%, p=0.063) resulting in a minimal agreement between the two criteria in diagnosing an FGID (kappa 0.34, agreement of 70%). The prevalence of functional constipation according to Rome IV was significantly lower compared to Rome III (13.5% vs 31.3%, p<0.001), whereas functional dyspepsia had a higher prevalence according to Rome IV than Rome III (11.5% vs 0%).Conclusion: We found an overall minimal agreement in diagnosing FGIDs according to Rome III and Rome IV criteria. This may be partly explained by the differences in diagnostic criteria. However, limitations with the use of questionnaires to measure prevalence have to be taken into account. What is Known:• The Rome IV criteria replaced the previous Rome III criteria providing updated criteria to diagnose functional gastrointestinal disorders (FGIDs).• Differences found between Rome IV and historic Rome III FGID prevalence may have been affected by changes in prevalence over time or differences in sample characteristics. What is New:• We found a minimal agreement between Rome III and Rome IV FGID diagnosis, especially in the diagnoses of functional constipation, irritable bowel syndrome, and functional dyspepsia.• The minimal agreement may be partly explained by changes in diagnostic criteria, but limitations with the use of questionnaires to measure prevalence have to be taken into account.

Tu1638 - Reliabilty of, and Agreement Between, Rome III and Rome IV Irritable Bowel Syndrome (IBS) Subtyping by Means of Stool Diary

2018 ◽  
Vol 154 (6) ◽  
pp. S-977
Author(s):  
Olafur S. Palsson ◽  
Magnus Simren ◽  
Carolyn S. Higgins ◽  
Susan M. Fox ◽  
Jeffrey M. Johnston ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Rome Iii ◽  
Irritable Bowel ◽  
Rome Iv

scholarly journals Irritable bowel syndrome is underdiagnosed and ineffectively managed among endurance athletes

2019 ◽  
Vol 44 (12) ◽  
pp. 1329-1338
Author(s):  
Lauren A. Killian ◽  
Soo-Yeun Lee
Keyword(s):  
Irritable Bowel Syndrome ◽  
Diagnostic Criteria ◽  
Symptom Management ◽  
Mitigation Strategies ◽  
Endurance Athletes ◽  
Online Questionnaire ◽  
Total Prevalence ◽  
Gi Symptoms ◽  
Rome Iii ◽  
Irritable Bowel

Lower gastrointestinal (GI) symptoms are common among endurance athletes and can impair performance. Symptom characteristics are similar to irritable bowel syndrome (IBS). No previous research has examined IBS diagnosis (medically or by diagnostic criteria) within this population. The objectives of this study were to determine the prevalence of IBS among endurance athletes and examine their GI symptom management strategies. A previously validated, online questionnaire assessed IBS diagnosis, the meeting of IBS diagnostic criteria (Rome III or Manning), general GI symptoms, and symptom mitigation strategies of endurance athletes. The questionnaire was distributed to United States athletes completing a marathon, ultra-marathon, half-distance triathlon, or full-distance triathlon. Medically diagnosed IBS was reported by 2.8% of endurance athletes. The total prevalence of IBS (n = 430) was 9.8% (medical diagnosis and Rome III). Athletes with IBS experienced more frequent symptoms during exercise as well as at rest; however, only 47.6% had consulted a medical professional. Over 56% of athletes experienced at least 1 symptom sometimes, often, or always during training and competition and 18.6% had symptoms that sometimes or often interrupted/prevented training. Almost half (45.8%) of athletes and 80.0% of athletes with IBS reported trying nutritional modifications to help ease symptoms while 20.6% and 52.4% used over-the-counter medications, respectively. Novelty Most endurance athletes who suffer from IBS are undiagnosed, while even more experience GI symptoms but do not fit diagnostic criteria. Despite using various symptom management methods, endurance athletes are still experiencing symptoms and could potentially benefit from current IBS-mitigating strategies.

Mo1642 Population Prevalence of Rome IV and Rome III Irritable Bowel Syndrome (IBS) in the United States (US), Canada and the United Kingdom (UK)

2016 ◽  
Vol 150 (4) ◽  
pp. S739-S740 ◽  
Author(s):  
Olafur S. Palsson ◽  
Miranda A. van Tilburg ◽  
Magnus Simren ◽  
Ami D. Sperber ◽  
William E. Whitehead
Keyword(s):  
United States ◽  
Irritable Bowel Syndrome ◽  
United Kingdom ◽  
The United States ◽  
The United Kingdom ◽  
Population Prevalence ◽  
Rome Iii ◽  
Irritable Bowel ◽  
Rome Iv

Comparación entre los criterios diagnósticos del síndrome de intestino irritable en una población latinoamericana. Estudio descriptivo de un hospital de atención terciaria

2021 ◽  
Vol 51 (2) ◽  
Author(s):  
Tatiana Noemí Uehara ◽  
Harumi Hashimoto ◽  
Federico Bazán ◽  
Adriana Tévez ◽  
Gladys Bravo ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Care Hospital ◽  
Cross Sectional ◽  
Rome Iii ◽  
Irritable Bowel ◽  
Diagnosis Criteria ◽  
Rome I ◽  
Rome Iv

Background and aims. The appropriate diagnosis of irritable bowel syndrome is critical due to its association with impaired quality of life and high health care costs. We aim to explore the proportion of subjects with irritable bowel syndrome by the Rome IV criteria at a tertiary care hospital and compare them with previous diagnostic criteria. Material and methods. We conducted a cross-sectional descriptive study in a tertiary care hospital located in Buenos Aires. There were included to the consecutive adult patients who consulted for abdominal disorders and in whom an organic pathology had been excluded. Subjects completed a gastrointestinal symptom questionnaire and the proportion of patients with IBS, according to Roma IV criteria, was compare with the proportion of those who met the previous criteria (Manning, Rome I, II and III). Results. Of 178 patients included, 58% met the diagnosis criteria for IBS using the Rome IV criteria. Of these, 98% were also Rome III positive, 76.7% IBS Rome II positive, 93% IBS Rome I positive and 99% IBS Manning positive. The agreement was very good with Rome III (kappa = 0.87), good with Rome I (kappa = 0.76) and good, but lower with Rome II (kappa = 0.73) and Manning (kappa = 0.66). Conclusions. Good diagnostic agreement was established between Rome IV and the previous IBS criteria, except with Rome II and Manning, which were lower.

Sign in / Sign up

Export Citation Format

Share Document